Share-based Payment Arrangement, Expense in USD of INTERPACE BIOSCIENCES, INC. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Interpace Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q1 2015 to Q3 2025.
  • Interpace Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $7K, a 91.9% decline year-over-year.
  • Interpace Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $104K, a 70% decline year-over-year.
  • Interpace Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $291K, a 53.8% decline from 2023.
  • Interpace Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $630K, a 47.1% decline from 2022.
  • Interpace Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.19M, a 15.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

INTERPACE BIOSCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $104K $7K -$79K -91.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $183K $9K -$44K -83% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $227K $15K -$64K -81% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $291K $73K -$56K -43.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $347K $86K -$66K -43.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $413K $53K -$104K -66.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $517K $79K -$113K -58.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $630K $129K +$47K +57.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $583K $152K -$349K -69.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $932K $157K -$148K -48.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.08M $192K -$111K -36.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.19M $82K +$315K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $876K $501K +$73K +17.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $803K $305K -$246K -44.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.05M $303K +$17K +5.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.03M -$233K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $428K -$135K -24% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $551K +$151K +37.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $286K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $563K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $400K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2018 $1.56M $600K +$500K +500% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $1.06M $560K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $300K +$100K +50% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $100K -$100K -50% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $100K $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $200K -$100K -33.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $200K -$300K -60% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $100K -$100K -50% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2015 $300K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 $500K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $200K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12

INTERPACE BIOSCIENCES, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $291K -$339K -53.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $630K -$561K -47.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $1.19M +$159K +15.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.03M -$1.16M -52.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $2.19M +$652K +42.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $1.54M -$199K -11.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-01
2018 $1.73M +$674K +63.6% Jan 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
2017 $1.06M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.